Showing results (311-320 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|March 15, 2011
Bivalirudin: a pharmacoeconomic profile of its use in patients with acute coronary syndromesKatherine A Lyseng-WilliamsonPharmacoeconomics|May 4, 2011
Prioritizing comparative effectiveness research: are drug and implementation trials equally worth funding?Afschin GandjourPharmacoeconomics|May 19, 2011
Cost estimation of cardiovascular disease events in the USAmy K O'Sullivan, Jaime Rubin, Joshua Nyambose, et al.Pharmacoeconomics|May 25, 2011
Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?Wendy J UngarPharmacoeconomics|May 25, 2011
Cost-of-illness studies: a guide to critical evaluationAllison Larg, John R MossPharmacoeconomics|June 4, 2011
Estimating the relationship between preference-based generic utility instruments and disease-specific quality-of-life measures in severe chronic constipation: challenges in practiceMark Parker, Alan Haycox, Jane GravesPharmacoeconomics|May 24, 2011
Using QALYs in cancer: a review of the methodological limitationsMartina Garau, Koonal K Shah, Anne R Mason, et al.Pharmacoeconomics|January 20, 2011
A model to transfer trial-based pharmacoeconomic analyses to clinical practiceAfschin GandjourPharmacoeconomics|January 20, 2011
Cost effectiveness of treatments for wet age-related macular degenerationPaul Mitchell, Lieven Annemans, Richard White, et al.Pharmacoeconomics|October 13, 2010
An analysis of NICE's 'restricted' (or 'optimized') decisionsPhill O'Neill, Nancy J DevlinPageof 335